Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 1.330
+0.022 (1.68%)
Jul 3, 2026, 5:29 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 453.28 million as of July 2, 2026. Its market cap has increased by 40.89% in one year.
Market Cap
453.28M
Enterprise Value
308.01M
Revenue
18.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.33
Market Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 453.28M, an increase of 428.33%. That is a compound annual growth rate of 19.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 453.28M | 43.94% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 941.65M |
| Xspray Pharma AB | 723.58M |
| AlzeCure Pharma AB | 712.47M |
| Oncopeptides AB | 649.85M |
| FluoGuide | 622.91M |
| Cantargia AB | 523.08M |
| Corline Biomedical AB | 482.16M |
| Sprint Bioscience AB | 450.55M |